These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 23880036)
1. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain. Marutle A; Gillberg PG; Bergfors A; Yu W; Ni R; Nennesmo I; Voytenko L; Nordberg A J Neuroinflammation; 2013 Jul; 10():90. PubMed ID: 23880036 [TBL] [Abstract][Full Text] [Related]
2. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer's Brain Tissue. Ni R; Röjdner J; Voytenko L; Dyrks T; Thiele A; Marutle A; Nordberg A J Alzheimers Dis; 2021; 80(4):1723-1737. PubMed ID: 33749648 [TBL] [Abstract][Full Text] [Related]
3. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. Ni R; Marutle A; Nordberg A J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213 [TBL] [Abstract][Full Text] [Related]
4. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. Carter SF; Schöll M; Almkvist O; Wall A; Engler H; Långström B; Nordberg A J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821 [TBL] [Abstract][Full Text] [Related]
5. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384 [TBL] [Abstract][Full Text] [Related]
6. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease. Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Kadir A; Marutle A; Gonzalez D; Schöll M; Almkvist O; Mousavi M; Mustafiz T; Darreh-Shori T; Nennesmo I; Nordberg A Brain; 2011 Jan; 134(Pt 1):301-17. PubMed ID: 21149866 [TBL] [Abstract][Full Text] [Related]
8. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Gulyás B; Pavlova E; Kása P; Gulya K; Bakota L; Várszegi S; Keller E; Horváth MC; Nag S; Hermecz I; Magyar K; Halldin C Neurochem Int; 2011 Jan; 58(1):60-8. PubMed ID: 21075154 [TBL] [Abstract][Full Text] [Related]
9. Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by Lemoine L; Saint-Aubert L; Nennesmo I; Gillberg PG; Nordberg A Sci Rep; 2017 Apr; 7():45496. PubMed ID: 28374768 [TBL] [Abstract][Full Text] [Related]
10. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach. Rodriguez-Vieitez E; Kumar A; Malarte ML; Ioannou K; Rocha FM; Chiotis K Methods Mol Biol; 2024; 2785():195-218. PubMed ID: 38427196 [TBL] [Abstract][Full Text] [Related]
11. Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Rosen RF; Ciliax BJ; Wingo TS; Gearing M; Dooyema J; Lah JJ; Ghiso JA; LeVine H; Walker LC Acta Neuropathol; 2010 Feb; 119(2):221-33. PubMed ID: 19690877 [TBL] [Abstract][Full Text] [Related]
12. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease. Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052 [TBL] [Abstract][Full Text] [Related]
13. Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques. Driscoll I; Troncoso JC; Rudow G; Sojkova J; Pletnikova O; Zhou Y; Kraut MA; Ferrucci L; Mathis CA; Klunk WE; O'Brien RJ; Davatzikos C; Wong DF; Resnick SM Acta Neuropathol; 2012 Dec; 124(6):823-31. PubMed ID: 22864813 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease. Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271 [TBL] [Abstract][Full Text] [Related]
15. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Yu WF; Guan ZZ; Bogdanovic N; Nordberg A Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636 [TBL] [Abstract][Full Text] [Related]
16. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Svedberg MM; Hall H; Hellström-Lindahl E; Estrada S; Guan Z; Nordberg A; Långström B Neurochem Int; 2009; 54(5-6):347-57. PubMed ID: 19162107 [TBL] [Abstract][Full Text] [Related]
17. Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease. Olsen M; Aguilar X; Sehlin D; Fang XT; Antoni G; Erlandsson A; Syvänen S Mol Imaging Biol; 2018 Aug; 20(4):605-614. PubMed ID: 29297157 [TBL] [Abstract][Full Text] [Related]
18. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9. Lemoine L; Gillberg PG; Bogdanovic N; Nennesmo I; Saint-Aubert L; Viitanen M; Graff C; Ingelsson M; Nordberg A Mol Psychiatry; 2021 Oct; 26(10):5609-5619. PubMed ID: 32581318 [TBL] [Abstract][Full Text] [Related]